GL1X · GenesisL1 explorer

MolNFT v1 · #62118 · protein

Fragment based discovery of JAK-2 inhibitors

3E64 · Tyrosine-protein kinase JAK2: “Fragment based discovery of JAK-2 inhibitors”. X-ray diffraction, 1 ligand (5B3), 2 pockets (best druggability 0.71). MolNFT v1 #62118 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3E64
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
5B3
Pockets
2 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29344% helix, 19% strandO60674

Ligands and binding sites

  • 5B3 · 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15700.710.80605B3
2510.270.7416empty

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 3E64 · Fragment based discovery of JAK-2 inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.